Fig. 2From: SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system Case demographics. Key characteristics of the AF reports are shown: age category (a), sex (b), drug role (c), reporting source (d). SGLT2i, sodium glucose cotransporter-2 inhibitors. ATC anatomic therapeutic classification, HCP health care professional. Numbers inscribed within stacked bars are percentagesBack to article page